<?xml-stylesheet type='text/xsl' href='ctgovTransform.xsl'?>
<CT.GOV_Trial requestNumber="6474">
  <stage>Registered</stage>
  <submitdate>20/04/2017</submitdate>
  <approvaldate>20/04/2017</approvaldate>
  <nctid>NCT03148600</nctid>
  <trial_identification>
    <studytitle>Rehabilitation After Ileo-anal Pouch Surgery</studytitle>
    <scientifictitle>Behavioural Treatment Following Ileo-Anal Pouch Formation:</scientifictitle>
    <utrn />
    <trialacronym>RAP</trialacronym>
    <secondaryid>HREC/16/SVHM/214</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Colonic Pouches</healthcondition>
    <healthcondition>Physical Therapy Modalities</healthcondition>
    <healthcondition>Biofeedback</healthcondition>
  </conditions>
  <interventions>
    <interventions>Behaviour - Pelvic floor and bowel behavioural training
Other interventions - Standard arm

Active Comparator: Intervention arm - Pelvic floor and bowel behavioural training programme provided by physiotherapists over 2- 6 sessions within the 6 months following ileostomy closure for patients with an ileo-anal pouch

Placebo Comparator: Standard arm - Standard post-operative nursing and medical care provided in hospital clinic


Behaviour: Pelvic floor and bowel behavioural training
Physiotherapist-led pelvic floor muscle and bowel behavioural training

Other interventions: Standard arm
Standard medical and nursing care

</interventions>
    <comparator />
    <control />
    <interventioncode>Behaviour</interventioncode>
    <interventioncode>Other interventions interventions</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Colo Rectal Functional Outcome Score (COREFO) - Proportion of patients achieving &gt; 50% reduction in score</outcome>
      <timepoint>1,3, 6 and 12 months following ileostomy reversal</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Pouch Dysfunction score - Comparison of scores between groups</outcome>
      <timepoint>1,3,6 and 12 months following ileostomy closure</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Quality of Life Short-Form 36 (SF-36) - Quality of life SF-36 compared between groups - mental health domain, physical health domain and total score</outcome>
      <timepoint>Baseline, 3,6 and 12 months following ileostomy closure</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Quality of Life EQ-5D - Scores from the EQ-5D will be compared between groups and quality adjusted life years (QALY) will be derived from EQ-5D.</outcome>
      <timepoint>Baseline,3,6 and 12 months following ileostomy closure</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Inflammatory Bowel Disease Questionnaire (IBDQ) - Disease specific quality of life score comparing groups</outcome>
      <timepoint>Baseline,3,6 and 12 months following ileostomy closure</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Hospital Anxiety and Depression Scale (HADs) - Psychological well being scores for anxiety and depression comparing groups</outcome>
      <timepoint>Baseline,3,6 and 12 months following ileostomy closure</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Brief Illness Perception Questionnaire - Between group comparison of cognitive and emotional perceptions of illness</outcome>
      <timepoint>Baseline,3,6 and 12 months following ileostomy closure</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Brief Cope - Between group comparison of coping styles and ability to cope with stress</outcome>
      <timepoint>Baseline,3,6 and 12 months following ileostomy closure</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>New General Self-Efficacy Scale - Between group comparison of confidence in ability to perform tasks and achieve goals</outcome>
      <timepoint>Baseline,3,6 and 12 months following ileostomy closure</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>-  Proven (documented) history of Ulcerative Colitis or Familial Adenomatous Polyposis

          -  Proctocolectomy and awaiting ileo-anal pouch formation or have had ileo-anal pouch
             created and are waiting for stoma reversal or have had stoma reversal within the last
             60 days</inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>80</inclusivemaxage>
    <inclusivemaxagetype>Years</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>-  Primary sclerosing cholangitis

          -  Significant medical or psychiatric comorbidity that in the opinion of the
             investigators would interfere with bowel function or adherence to the protocol

          -  Clinically significant narcotic or substance abuse that in the opinion of the
             investigators would interfere with bowel function or adherence to the protocol

          -  Recognised eating disorder

          -  Non- English speaking or illiterate

          -  Pregnancy

          -  Current participant in another trial</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment />
    <sequence />
    <masking>Blinded (masking used)</masking>
    <assignment>Parallel</assignment>
    <designfeatures />
    <endpoint />
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3>The people assessing the outcomes</masking3>
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Not Applicable</phase>
    <anticipatedstartdate />
    <actualstartdate>20/04/2017</actualstartdate>
    <anticipatedenddate />
    <actualenddate />
    <samplesize>60</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Recruiting</recruitmentstatus>
    <anticipatedlastvisitdate>31/12/2020</anticipatedlastvisitdate>
    <actuallastvisitdate />
    <dataanalysis />
    <withdrawnreason />
    <withdrawnreasonother />
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate>VIC</recruitmentstate>
    <hospital>St Vincent's Hospital - Fitzroy</hospital>
    <hospital>Alfred Health - Prahran</hospital>
    <postcode>3065 - Fitzroy</postcode>
    <postcode>3181 - Prahran</postcode>
  </recruitment>
  <sponsorship>
    <primarysponsortype>Other</primarysponsortype>
    <primarysponsorname>St Vincent's Hospital Melbourne</primarysponsorname>
    <primarysponsoraddress />
    <primarysponsorcountry />
  </sponsorship>
  <ethicsAndSummary>
    <summary>Multi-centre, assessor-blinded, randomised controlled trial comparing physiotherapist-led
      behavioural intervention (including pelvic floor muscle training) to standard care, in the
      management of post-operative ileo-anal pouch patients.</summary>
    <trialwebsite>https://clinicaltrials.gov/show/NCT03148600</trialwebsite>
    <publication />
    <ethicsreview />
    <publicnotes />
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Michael A Kamm, MBBS,PhD</name>
      <address>St Vincent's Hospital Melbourne</address>
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
    <contact>
      <title />
      <name>Angela J Khera, BAppSc</name>
      <address />
      <phone>+61 419 110 756</phone>
      <fax />
      <email>angela.khera@svhm.org.au</email>
      <country />
      <type>Public Queries</type>
    </contact>
  </contacts>
</CT.GOV_Trial>